European equities traded in the US as American depositary receipts were moving lower late Tuesday morning, declining 0.74% to 1,424.59 on the S&P Europe Select ADR Index. From continental Europe, the ...
The U.S. FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating schizophrenia. The fixed dose combination of xanomeline-trospium is the ...
The Gonorrhea drugs in development market research report provides comprehensive information on the therapeutics under development for Gonorrhea, complete ...
EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting ...
Agreement provides MSD with options to license Evaxion's preclinical, AI-designed vaccine candidates EVX-B2 and EVX-B3Evaxion will host a conference call and webcast to discuss the agreement on Septem ...